You are currently viewing a new version of our website. To view the old version click .
  • 0.6Impact Factor
  • 22 daysTime to First Decision

Reports, Volume 2, Issue 4

December 2019 - 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

  • Case Report
  • Open Access
13,497 Views
7 Pages

Anti-Diarrheal Effects of Wood Creosote, Seirogan, in Japanese Patients

  • Masanori Takagi,
  • Masafumi Ito,
  • Hirofumi Morino,
  • Takanori Miura,
  • Kyoichi Oshida,
  • Mayu Suzuki,
  • Hiroshi Takemori and
  • Takashi Shibata

10 December 2019

Wood creosote, Seirogan, is a non-prescription drug used to treat diarrhea. However, reports of its clinical use are rare. Here, we report the efficacy of wood creosote (3 capsules daily) in alleviating diarrheal symptoms in 148 patients from 10 clin...

  • Case Report
  • Open Access
3,237 Views
6 Pages

18 November 2019

A differential diagnosis of tuberculosis pleurisy is often difficult. A 48-year-old Japanese man with no previous medical history visited the outpatient department for dyspnea and fever. His chest-XP and laboratory findings, especially high C-reactiv...

  • Article
  • Open Access
18 Citations
7,366 Views
11 Pages

22 October 2019

Increasing radiologist workloads and increasing primary care radiology services make it relevant to explore the use of artificial intelligence (AI) and particularly deep learning to provide diagnostic assistance to radiologists and primary care physi...

  • Case Report
  • Open Access
3,581 Views
8 Pages

9 October 2019

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm constituting approximately 15% of newly diagnosed leukemia in adult patients. Development of tyrosine kinase inhibitors (TKIs) have dramatically improved outcomes in patients with chroni...

  • Article
  • Open Access
4 Citations
4,330 Views
10 Pages

5 October 2019

Background: Hepassocin is a liver-derived protein and its serum concentrations significantly increase in diabetes and fatty liver patients. Hepassocin is also a biomarker for diabetes and fatty liver; therefore, we aimed to investigate the impacts of...

  • Case Report
  • Open Access
5,421 Views
5 Pages

26 September 2019

Bio-Alcamid is a non-FDA approved permanent dermal filler with a few known adverse effects including granuloma formation at injection site, skin infections, abscess and painful inflammation. Embolization of Bio-Alcamid has not been reported and likel...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Reports - ISSN 2571-841X